Back
Neurocrine Biosciences Vs. Globus Medical Industry Stock Comparison
Buy
60
NBIX
Neurocrine Biosciences
Last Price:
142.31
Seasonality Move:
6.24%
Buy
55
GMED
Globus Medical
Last Price:
64.45
Seasonality Move:
3.48%
Buy
60
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $142.29. The Score for NBIX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Globus Medical (GMED)
is a Buy
Is Globus Medical a Buy, Sell or Hold?
- The current Globus Medical [GMED] share price is $64.40. The Score for GMED is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- GMED is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $142.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing buying pressure, which is a positive indicator for future bullish movement.
GMED Stock Price Chart
What is Globus Medical's stock price today?
-
The Globus Medical share price today is $64.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GMED is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 57.07 | Buy |
| Chaikin Money Flow: | 329489 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (134.45 - 141.57) | Buy |
| Bollinger Bands (100): | (133.08 - 140.72) | Buy |
GMED Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.4 | Buy |
| Relative Strength Index (14 RSI): | 73.03 | Buy |
| Chaikin Money Flow: | 629888 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.99 - 61.09) | Buy |
| Bollinger Bands (100): | (50.61 - 57.27) | Buy |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 139.52 | Buy |
| 20-day SMA: | 139.38 | Buy |
| 50-day SMA: | 138.59 | Buy |
| 200-day SMA: | 124.43 | Buy |
| 8-day EMA: | 140.43 | Buy |
| 20-day EMA: | 139.35 | Buy |
| 50-day EMA: | 137.87 | Buy |
| 200-day EMA: | 126.71 | Buy |
GMED Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.79 | Buy |
| 20-day SMA: | 56 | Buy |
| 50-day SMA: | 53.88 | Buy |
| 200-day SMA: | 52.21 | Buy |
| 8-day EMA: | 62.23 | Buy |
| 20-day EMA: | 58.17 | Buy |
| 50-day EMA: | 55.17 | Buy |
| 200-day EMA: | 54.04 | Buy |
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.04 per share, an increase this year of $1.88 per share, and an increase next year of $1.37 per share.
Globus Medical Earnings Growth & GMED Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.15 per share, an increase this year of $0.51 per share, and an increase next year of $0.49 per share.
Neurocrine Biosciences Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Globus Medical Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||